Key facts
- This page summarizes Mark Verratti's Form 4 filing for MYRIAD GENETICS INC (MYGN).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 01 May 2025, 16:27.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
The shares subject to the performance-based restricted stock units ("PSUs") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026.